Haploidentical Stem Cell Transplantation With Post-transplant Cyclophosphamide for Pediatric Acute Leukemia is Safe and Effective
Conclusion:
Haploidentical HSCT with PTCy is a safe and effective therapy for children with acute leukemia. Myeloablative conditioning and chronic GVHD lead to improved disease-free survival.
Source: Journal of Pediatric Hematology Oncology - Category: Hematology Tags: Online Articles: Clinical and Laboratory Observations Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Children | Chronic Leukemia | Hematology | Laboratory Medicine | Leukemia | Pediatrics | Prograf | Restasis | Rituxan | Stem Cell Therapy | Stem Cells | Tacrolimus | Transplants